FDA Cites Indian Manufacturer for Training, Record Deficiencies

Drug Industry Daily
A A
The FDA hit Indian injectable drugmaker Auronext Pharma over violations found during a February inspection of the company’s Bhiwadi, Rajasthan facility.

To View This Article:

Login

Subscribe To Drug Industry Daily